  | D'Uonnolo, G.* , Isci, D.* , Nosirov, B., Kuppens, A., Wantz, M., Nazarov, P., Golebiewska, A., Rogister, B., Chevigné, A.* , Neirinckx, V.* , & Szpakowska, M.*. (November 2024). Patient-based multilevel transcriptome exploration highlights relevant chemokines and chemokine receptor axes in glioblastoma. Computers in Biology and Medicine, 182, 109197. doi:10.1016/j.compbiomed.2024.109197  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Isci, D. (2024). Multilevel investigation of the atypical chemokine receptor 3 (ACKR3) expression and function in glioblastoma [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/323925 |
 | Lombard, A.* , Isci, D.* , Reuter, G., Di Valentin, E., Hego, A., Martin, D., Rogister, B., & Neirinckx, V. (28 September 2024). Development of an intraventricular Adeno-Associated Virus-based labelling strategy for glioblastoma cells nested in the subventricular zone. Neuro-Oncology Advances. Neuro-Oncology Advances, vdae161. doi:10.1093/noajnl/vdae161 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Isci, D., Kuppens, A., Scalisi, J., COKAIKO, J., Wantz, M., Szpakowska, M., Chevigné, A., Rogister, B., & Neirinckx, V. (2024). Heterogeneous expression of the atypical chemokine receptor ACKR3 in glioblastoma patient-derived tissue samples and cell cultures. Scientific Reports, 14, 21925. doi:10.1038/s41598-024-73064-w Peer Reviewed verified by ORBi |
 | Simonet, A., Isci, D., Neirinckx, V., Jerusalem, G., & Rogister, B. (06 December 2023). 190P Immune-related roles of B7H3 in glioblastoma [Poster presentation]. ESMO Immuno-oncology. doi:10.1016/j.iotech.2023.100649 Editorial reviewed |
Isci, D., Kuppens, A., COKAIKO, J., Chevigné, A., Rogister, B., & Neirinckx, V. (31 August 2023). Unveiling the secrets of ACKR3 in glioblastoma cells [Poster presentation]. ONCORNET2.0 Final Symposium 2023, Amsterdam, Netherlands. Peer reviewed |
 | Sanchez Gil, J., Dubois, M., Neirinckx, V., LOMBARD, A., Coppieters't Wallant, N., D'arrigo, P., Isci, D., Aldenhoff, T., Brouwers, B., Lassence, C., ROGISTER, B., Lebrun, M., & Sadzot, C. (2022). Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: a proof-of-principle. Molecular Therapy: Oncolytics. doi:10.1016/j.omto.2022.06.002 Peer Reviewed verified by ORBi |
 | Isci, D., Veiga, D., Cokaiko, J., LOMBARD, A., Chevigné, A., ROGISTER, B., & Neirinckx, V. (10 April 2022). Study of the ACKR3/CXCR7 receptor in glioblastoma [Poster presentation]. Télévie Seminar, Liège, Belgium. Peer reviewed |
 | Isci, D.* , D'Uonnolo, G.* , Wantz, M., Rogister, B., LOMBARD, A., Chevigné, A., Szpakowska, M., & Neirinckx, V. (28 December 2021). Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers, 14 (1), 130. doi:10.3390/cancers14010130 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Sanchez Gil, J., D'arrigo, P., Neirinckx, V., Isci, D., Brouwers, B., LOMBARD, A., Rogister, B., Lebrun, M., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted Oncolytic Herpesvirus (oHSV): proof of concept [Paper presentation]. IHW2021: 45th International Herpesvirus Workshop. |
Sanchez Gil, J., D'arrigo, P., Lebrun, M., Isci, D., Coppieters, N., Rogister, B., Chevigné, A., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted oncolytic herpesvirus [Poster presentation]. Journée des chercheurs Télévie. |
Dataset: